Dispatch from Breaking Convention 2025: Key Takeaways from Europe’s Largest Psychedelic Summit (Part 2) Post published:May 12, 2025 Post category:Analysis/News
Colorado’s Psilocybin Supply Chain Complete: First Testing Lab Licensed, Sessions Could Begin This Month Post published:May 10, 2025 Post category:Analysis/News
Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First Look at Gilgamesh’s Phase 2a Data; ASCP 2025 Preview; VA Sec. Pressed on Psychedelics Plans Post published:May 9, 2025 Post category:Psychedelic Bulletin/Pα+
EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic Access for Veterans Post published:May 6, 2025 Post category:Analysis/News
Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting; Noma Therapy Aims to Disrupt At-Home Ketamine; Christian Angermayer on the Politics and Business of Psychedelics, Bitcoin Post published:May 2, 2025 Post category:Psychedelic Bulletin/Pα+
March & April 2025 Psychedelic Patent Update: Lykos’ Patent Woes Continue; Filings Provide First Look at Seaport’s 2-Bromo-LSD Program; Delix’s Ergoline Analogues; CaaMTech’s Spinout Post published:May 1, 2025 Post category:Psychedelic Patent Analysis/Pα+
Dispatch from Breaking Convention 2025: Insights from Europe’s Largest Psychedelic Research Conference (Part 1) Post published:April 29, 2025 Post category:Analysis/News
Pα+ Psychedelic Bulletin #194: Make-or-Break Moment Looms for Compass; RFK Jr. Discusses LSD Use; Europe’s Next Chapter in Psychedelic Therapy Begins in Barcelona Post published:April 25, 2025 Post category:Psychedelic Bulletin/Pα+
Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride Post published:April 18, 2025 Post category:Interviews/Pα+